http://rdf.ncbi.nlm.nih.gov/pubchem/reference/2496897

Outgoing Links

Predicate Object
contentType Journal Article|Research Support, Non-U.S. Gov't
endingPage 1487
issn 1479-6694
1744-8301
issueIdentifier 10
pageRange 1477-1487
publicationName Future oncology (London, England)
startingPage 1477
bibliographicCitation Moretti E, Desmedt C, Biagioni C, Regan MM, Oakman C, Larsimont D, Galardi F, Piccart-Gebhart M, Sotiriou C, Rimm DL, Di Leo A. TOP2A protein by quantitative immunofluorescence as a predictor of response to epirubicin in the neoadjuvant treatment of breast cancer. Future Oncol. 2013 Oct;9(10):1477–87. doi: 10.2217/fon.13.103. PMID: 24106899.
creator http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_ee62b9a99d571b45de886e6e57111b85
http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_dfd1b83665e9cb46775a61f681cf8cc7
http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_29b418ae56d15067f959711568913f53
http://rdf.ncbi.nlm.nih.gov/pubchem/author/ORCID_0000-0002-8114-4668
http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_116d751bf052d87a524cc4310ad92006
http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_a4583b50a92b75456803b2b32ab382fe
http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_61a9a4e75d783a24eec2a7a79def861b
http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_4fab7ae6174e1dc6d12263f0642ed4b1
http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_b5f6a494588e2dcd6693b44c9e3e491a
http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_25ecec34669c3bbbcc0b5e18f4398edc
http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_9234f89b41880c1b4c51255ed9744d49
http://rdf.ncbi.nlm.nih.gov/pubchem/author/ORCID_0000-0002-7908-4854
http://rdf.ncbi.nlm.nih.gov/pubchem/author/ORCID_0000-0002-5223-5579
http://rdf.ncbi.nlm.nih.gov/pubchem/author/ORCID_0000-0002-3665-9056
http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_ce90973300b3ba6d3a9ca9b28e836c85
date 201310
identifier https://pubmed.ncbi.nlm.nih.gov/24106899
https://doi.org/10.2217/fon.13.103
isPartOf http://rdf.ncbi.nlm.nih.gov/pubchem/journal/32856
https://portal.issn.org/resource/ISSN/1479-6694
https://portal.issn.org/resource/ISSN/1744-8301
language English
source https://www.crossref.org/
https://pubmed.ncbi.nlm.nih.gov/
title TOP2A protein by quantitative immunofluorescence as a predictor of response to epirubicin in the neoadjuvant treatment of breast cancer
discusses http://id.nlm.nih.gov/mesh/M0006678
http://id.nlm.nih.gov/mesh/M0483897
http://id.nlm.nih.gov/mesh/M0001435
http://id.nlm.nih.gov/mesh/M0023488
http://id.nlm.nih.gov/mesh/M0001483
http://id.nlm.nih.gov/mesh/M000630001
http://id.nlm.nih.gov/mesh/M0381050
http://id.nlm.nih.gov/mesh/M0545767
hasPrimarySubjectTerm http://id.nlm.nih.gov/mesh/D059005Q000627
http://id.nlm.nih.gov/mesh/D004250Q000378
http://id.nlm.nih.gov/mesh/D001943Q000188
http://id.nlm.nih.gov/mesh/D001943Q000378
http://id.nlm.nih.gov/mesh/D015251Q000627
http://id.nlm.nih.gov/mesh/D000951Q000378
http://id.nlm.nih.gov/mesh/D000970Q000627
http://id.nlm.nih.gov/mesh/D004268Q000378
hasSubjectTerm http://id.nlm.nih.gov/mesh/D002467Q000378
http://id.nlm.nih.gov/mesh/D001943Q000401
http://id.nlm.nih.gov/mesh/D021381
http://id.nlm.nih.gov/mesh/D005260
http://id.nlm.nih.gov/mesh/D007150
http://id.nlm.nih.gov/mesh/D006801
http://id.nlm.nih.gov/mesh/D020360
http://id.nlm.nih.gov/mesh/D011379
http://id.nlm.nih.gov/mesh/D000075223
http://id.nlm.nih.gov/mesh/D004268Q000235
http://id.nlm.nih.gov/mesh/D003593Q000378
http://id.nlm.nih.gov/mesh/D000951Q000235
http://id.nlm.nih.gov/mesh/D004250Q000235
discussesAsDerivedByTextMining http://rdf.ncbi.nlm.nih.gov/pubchem/gene/MD5_e8ad08f759b2798c1b5dca78861cc6ce
http://rdf.ncbi.nlm.nih.gov/pubchem/disease/DZID8607
http://rdf.ncbi.nlm.nih.gov/pubchem/disease/DZID7102
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID41867
http://rdf.ncbi.nlm.nih.gov/pubchem/gene/MD5_43830973f74de180729ad1e755d592ad
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID30323
http://rdf.ncbi.nlm.nih.gov/pubchem/gene/MD5_af1895113f1c47d686d56c8b43fe0a29
http://rdf.ncbi.nlm.nih.gov/pubchem/gene/MD5_e1afa113b0d884f36154ce9339375de8

Showing number of triples: 1 to 71 of 71.